Optimal oncologic and perioperative outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy are attainable at a community center
- 18 March 2021
- journal article
- research article
- Published by Elsevier in The American Journal of Surgery
- Vol. 221 (6) , 1200-1202
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Peritoneal Cancers and Hyperthermic Intraperitoneal ChemotherapySurgical Clinics of North America, 2020
- Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Technical considerations and the learning curveJournal of Surgical Oncology, 2020
- The Chicago Consensus on peritoneal surface malignancies: StandardsCancer, 2020
- Evaluation of cytoreductive surgery and HIPEC for peritoneal surface malignancies: analysis of 384 consecutive casesLangenbeck's Archives of Surgery, 2019
- Postoperative Complications Independently Predict Cancer-Related Survival in Peritoneal MalignanciesAnnals of Surgical Oncology, 2018
- Early experience with cytoreduction and hyperthermic intraperitoneal chemotherapy at a newly developed center for peritoneal malignancyJournal of Gastrointestinal Oncology, 2018
- Institutional Learning Curve of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Peritoneal MalignanciesAnnals of Surgical Oncology, 2014
- Learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies: Analysis of two centresJournal of Surgical Oncology, 2012